C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/17/2002	WO2002080983A1 Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins
10/17/2002	WO2002080982A2 Nucleic acid mucosal immunization
10/17/2002	WO2002080981A2 Polynucleotide binding complexes comprising sterols and saponins
10/17/2002	WO2002080973A1 Composition for use in therapy of hard tissue of mammal and method of therapy thereof
10/17/2002	WO2002080958A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/17/2002	WO2002080952A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
10/17/2002	WO2002080888A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation
10/17/2002	WO2002080852A2 Genes expressed in intestinal epithelium and peyer's patch m cells
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080849A2 Chemotherapeutic induction of egr-1 promoter activity
10/17/2002	WO2002080848A2 Methods and materials for cancer treatment
10/17/2002	WO2002080847A2 Use of tumor necrosis factor inhibitors to treat cardiovascular disease
10/17/2002	WO2002080846A2 Epothilone derivatives and methods for making and using the same
10/17/2002	WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080755A2 Kits and methods for assessing oxidative stress
10/17/2002	WO2002080659A1 Nucleic acids that control reproductive development in plants
10/17/2002	WO2002080648A2 Mucosal boosting following parenteral priming
10/17/2002	WO2002068672A3 Antisense modulation of recql4 expression
10/17/2002	WO2002063036A3 Vector system used in screening active substances
10/17/2002	WO2002063021A3 Nucleotide sequence mediating male fertility and method of using same
10/17/2002	WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002	WO2002059140A3 Ikaros rgulatory elements and uses thereof
10/17/2002	WO2002054851A3 Inhibition of pathological angiogenesis in vivo
10/17/2002	WO2002052024A3 Elongase promoters
10/17/2002	WO2002050259A3 Compositions, methods and kits for identifying protein-protein interaction disrupting agents
10/17/2002	WO2002048164A3 Isolation of nucleic acids
10/17/2002	WO2002046432A3 Modulating gene expression in insects by using double-stranded rna (dsrna)
10/17/2002	WO2002044205A3 Peptides from ag85 of mycobacterium and uses thereof
10/17/2002	WO2002043757A3 Medicament for preventing or treating tumors caused by human papilloma virus type 18
10/17/2002	WO2002042440A3 Regulation of plant growth by modifying the expression of a putative trna-isope ntenyl transferase
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002040665A3 Complementing cell lines
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002036754A3 Nucleotide and polypeptide sequence of human lysosomal acid lipase
10/17/2002	WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002026966A3 Transfection using plasmid preparations
10/17/2002	WO2002026824A3 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues
10/17/2002	WO2002023983A3 Method of producing non-human mammals
10/17/2002	WO2002022869A3 Directed evolution method
10/17/2002	WO2002022837A3 Identification and characterization of a dwarf and late flowering 2 phenotype (dlf2) in arabidopsis
10/17/2002	WO2002020800A9 16658, 14223, and 16002, NOVEL HUMAN KINASES AND USES THEREFOR
10/17/2002	WO2002020548A9 Monocot seeds with increased lignan content
10/17/2002	WO2002018568A3 Molecules involved in the regulation of insulin in resistance syndrome (irs)
10/17/2002	WO2002016435A3 Human 7tm proteins and polynucleotides encoding the same
10/17/2002	WO2002016417A3 Transgenic animal model for neurodegerative disease and uses thereof
10/17/2002	WO2002012463A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
10/17/2002	WO2002010417A3 Methods and compositions for the construction and use of viral envelops as display particles
10/17/2002	WO2002009645A3 Intercellular transport protein linked to an antigen as a molecular vaccine
10/17/2002	WO2002008420A3 A method of down-regulating gene expression
10/17/2002	WO2002006457A3 Novel lipase genes
10/17/2002	WO2002006326A3 62088, a human nucleoside phosphatase family member and uses thereof
10/17/2002	WO2002004669A3 Improved capture and detection format versatility for dipstick assays
10/17/2002	WO2002004645A3 A second human heparanase, and splice variants thereof, with a predominant expression in skeletal muscle, heart and pancreas
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	WO2002002148A3 Dual recombinant gene therapy compositions and methods of use
10/17/2002	WO2002000871A3 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
10/17/2002	WO2002000843A3 56739, a novel cub domain containing protein and uses thereof
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001096585A3 Modulation of abscisic acid signal transduction in plants
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001085968A3 Production of conjugated linoleic and linolenic acids in plants
10/17/2002	WO2001084148A3 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
10/17/2002	WO2001081551A3 Retinal pigment epithelial cell lines with extended life-span and their applications
10/17/2002	WO2001079560A3 Medicine response assay in respiratory disease
10/17/2002	WO2001079294A3 Human proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2001077378A3 Diagnosis of diseases associated with dna adducts
10/17/2002	WO2001075077A3 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
10/17/2002	WO2001060847A9 Avirulent, immunogenic flavivirus chimeras
10/17/2002	WO2001059118A9 43239, a gpcr-like molecule and uses thereof
10/17/2002	WO2001059117A9 Seven-transmembrane proteins/g-protein coupled receptors
10/17/2002	WO2001059116A9 19459 protein, a human g-protein coupled seven transmembrane receptor
10/17/2002	WO2001059101A9 Method for amplifying full length single strand polynucleotide sequences
10/17/2002	WO2001059094A9 Method of regulating transcription in a cell by altering remodeling of cromatin
10/17/2002	WO2001058922A9 Method and compositions for treating hepatocellular cancer
10/17/2002	WO2001057275A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
10/17/2002	WO2001055410A9 Ceramidase compositions and methods based thereon
10/17/2002	WO2001055370A9 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
10/17/2002	WO2001054510A9 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002	WO1998002456A3 Human c-type lectin
10/17/2002	US20020152502 Transgenic plant; tolerance of environment stresses
10/17/2002	US20020152501 Nucleic acids that control seed and fruit development in plants
10/17/2002	US20020152500 Tissue-preferred promoter from maize
10/17/2002	US20020152499 Gene encoding a protein involved in the signal transduction cascade leading to systemic acquired resistance in plants
10/17/2002	US20020152498 Mutant plant
10/17/2002	US20020152497 Nucleic acid fragments encoding proteins involved in stress response
10/17/2002	US20020152496 Coleopteran toxin proteins of bacillus thuringiensis
10/17/2002	US20020152495 Plants having seedless fruit
10/17/2002	US20020152494 Adjustment chromosome sequences; transgenic animal
10/17/2002	US20020152493 Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions
10/17/2002	US20020152492 Modulate gene expression
10/17/2002	US20020152491 Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration
10/17/2002	US20020152489 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
10/17/2002	US20020152488 Genetically engineered animals for use as organ donors
10/17/2002	US20020152487 Transgenic animal; controlling transcription factor; administering tetracyclic promoter
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis

1 ... 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 ... 4023